(Q38163930)

30 August 2017

Treatment of the acquired immune deficiency syndrome (English)

1 reference

30 August 2017

S Gupta

1

1 reference

PubMed ID

2424929

30 August 2017

M S Gottlieb

series ordinal

2

1 reference

30 August 2017

1 May 1986

1 reference

Journal of Clinical Immunology

30 August 2017

1 reference

30 August 2017

6

1 reference

30 August 2017

3

1 reference

30 August 2017

183-193

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00918698

30 August 2017

0 references

cites work

Immunopathogenesis of the acquired immunodeficiency syndrome

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00918698

Prospects of therapy for infections with human T-lymphotropic virus type III.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00918698

Immunologic reconstitution in the acquired immunodeficiency syndrome

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00918698

The prospects for and pathways toward a vaccine for AIDS.

21 January 2018

1 reference

12 December 2020

Autologous mixed lymphocyte reaction in man. XIV. Deficiency of the autologous mixed lymphocyte reaction in acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC). In vitro effect of purified interleukin-1 and interleukin-2

1 reference

12 December 2020

Study of activated T cells in man. II. Interleukin 2 receptor and transferrin receptor expression on T cells and production of interleukin 2 in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex

1 reference

12 December 2020

Lymphocyte transfusion in case of acquired immunodeficiency syndrome

1 reference

12 December 2020

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

12 December 2020

Interaction of vesicular stomatitis virus with lipid vesicles: depletion of cholesterol and effect on virion membrane fluidity and infectivity

1 reference

12 December 2020

Transmission of HTLV-III Infection from Human Plasma to Chimpanzees: An Animal Model for AIDS

1 reference

12 December 2020

Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism

1 reference

12 December 2020

Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters

1 reference

12 December 2020

Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro.

1 reference

12 December 2020

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

12 December 2020

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

12 December 2020

In-vitro inhibition of LAV/HTLV-III infected lymphocytes by dithiocarb and inosine pranobex

1 reference

12 December 2020

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome

1 reference

12 December 2020

Bone-Marrow Transplantation in AIDS

1 reference

12 December 2020

Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes

1 reference

12 December 2020

Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo

1 reference

12 December 2020

In vitro effect of foscarnet on expansion of T-cells from people with LAS and AIDS

1 reference

12 December 2020

Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

1 reference

12 December 2020

Infection of chimpanzees with lymphadenopathy-associated virus

1 reference

12 December 2020

Monoclonal antibody-defined beta 2-microglobulin-positive mononuclear cells in acquired immune deficiency syndrome

1 reference

12 December 2020

Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes

1 reference

12 December 2020

Inhibition of HTLV-III/LAV replication by foscarnet

1 reference

12 December 2020

Partial immune reconstitution in a patient with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome

1 reference

12 December 2020

Enkephalins and endorphins as modifiers of the immune system: present and future

1 reference

12 December 2020

Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate

1 reference

12 December 2020

A Pathogenic Retrovirus (HTLV-III) Linked to AIDS

1 reference

12 December 2020

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

1 reference

12 December 2020

Pharmacological inhibition of infectivity of HTLV-III in vitro.

1 reference

12 December 2020

Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions

1 reference

12 December 2020

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

12 December 2020

Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Serum lactate dehydrogenase levels in adults and children with acquired immune deficiency syndrome (AIDS) and AIDS-related complex: possible indicator of B cell lymphoproliferation and disease activity. Effect of intravenous gammaglobulin on enzyme

1 reference

12 December 2020

Isoprinosine and Imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms

1 reference

12 December 2020

Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma

1 reference

12 December 2020

Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Thymosin in the staging and treatment of HTLV-III positive homosexuals and hemophiliacs with AIDS-related immune dysfunction.

1 reference

12 December 2020

A special lipid mixture for membrane fluidization

1 reference

12 December 2020

Heterogeneity of epidemic Kaposi's sarcoma. Implications for therapy

1 reference

12 December 2020

Short-term results with suramin for AIDS-related conditions

1 reference

12 December 2020

Thymic dysplasia in acquired immunodeficiency syndrome

1 reference

12 December 2020

Circulating immune complexes in AIDS

1 reference

12 December 2020

Low serum thymic hormone levels in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.

1 reference

12 December 2020

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

12 December 2020

Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.

1 reference

12 December 2020

HTLV-III, AIDS, and the brain.

1 reference

12 December 2020

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

1 reference

12 December 2020

Antigen-specific primary cytotoxic T lymphocyte (CTL) responses in acquired immune deficiency syndrome (AIDS) and AIDS-related complexes (ARC)

1 reference

12 December 2020

Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00918698

1 reference

PubMed ID

2424929

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

2424929